Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million. The clinical-stage Shifamed portfolio company also recently completed enrollment for its U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its percutaneous ventricular assist device (pVAD) for treating high-risk … [Read more...] about Supira Medical closes $120M Series E, completes enrollment in ventricular assist device study
Business
Evident Vascular closes Series B for AI-powered intravascular ultrasound
Evident Vascular announced today that it closed a Series B financing round to support its AI-powered intravascular ultrasound (IVUS) platform. The San Jose, California–based company did not disclose the amount raised in the Series B round. It adds to $35 million picked up in a Series A that brought the company out of stealth mode in 2023. … [Read more...] about Evident Vascular closes Series B for AI-powered intravascular ultrasound
Perfuze wins FDA nod for access catheter, raises $24M
Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding. The Galway, Ireland–based medtech company picked up about $24 million (€22 million) in a follow-on funding round. Existing investors, including Earlybird, EQT Life Sciences, Seroba and SV Health, participated in the … [Read more...] about Perfuze wins FDA nod for access catheter, raises $24M
NanoVibronix announces reverse stock split
NanoVibronix (Nasdaq:NAOV) announced today that it intends to effect a reverse stock split of its common stock. The split comes at a ratio of one post-split share for every 11 pre-split shares. Tyler, Texas-based NanoVibronix expects the split to go into effect at 4:05 p.m. on March 13, 2025. It plans for its common stock to continue trading on … [Read more...] about NanoVibronix announces reverse stock split
Reflow Medical expands global reach with European subsidiary
Reflow Medical announced today that it opened a European subsidiary in Landsberg am Lech, Germany, to expand outside the U.S. The company said its strategic expansion strengthens its international presence and enhances its ability to serve markets globally. SVP and GM Knut Saurteig leads the subsidiary, called Reflow Medical Europe GmbH. … [Read more...] about Reflow Medical expands global reach with European subsidiary
FTC challenges private equity firm’s acquisition of Surmodics
The U.S. Federal Trade Commission (FTC) has sued to block the planned acquisition of medical device company Surmodics by GTCR. According to a news release, GTCR also owns a majority stake in Biocoat. The FTC says Biocoat is the second-largest provider of outsourced hydrophilic medical device coatings, behind only Surmodics. As a result, the FTC … [Read more...] about FTC challenges private equity firm’s acquisition of Surmodics
Olympus launches single-use hemostasis clip
Olympus announced that it launched a new hemostasis clip to meet the needs of gastrointestinal (GI) endoscopists. The company's Retentia HemoClip offers 360° rotation and an intuitive one-step deployment. This provides control over placement with three different sizes to accommodate a variety of closure applications. Retentia HemoClip … [Read more...] about Olympus launches single-use hemostasis clip
J&J’s Shockwave Medical launches new IVL catheter
Johnson & Johnson MedTech‘s Shockwave Medical today announced the U.S. launch of its Javelin peripheral intravascular lithotripsy (IVL) catheter. The system is designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-balloon IVL platform delivers a similar … [Read more...] about J&J’s Shockwave Medical launches new IVL catheter
Boston Scientific to acquire renal denervation company SoniVie
Boston Scientific (NYSE:BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie. Marlborough, Massachusetts-based Boston Scientific is a strategic investor in SoniVie, holding about a 10% equity stake. With this stake, the transaction features an upfront payment of approximately $360 million for the 90% … [Read more...] about Boston Scientific to acquire renal denervation company SoniVie
Adagio Medical to restructure, reduce workforce
Adagio Medical (Nasdaq:ADGM) announced today that it plans a corporate restructuring and realignment of resources. The Laguna Hills, California–based company, which develops catheter ablation technologies for treating cardiac arrhythmias, wants to prioritize its FULCRUM-VT pivotal FDA investigational device exemption (IDE) clinical trial … [Read more...] about Adagio Medical to restructure, reduce workforce
